Stablepharma has initiated its first human trial of SPVX02, a thermostable fridge-free vaccine for tetanus-diphtheria designed to remain potent without…
Read More »clinical trial
A new experimental drug, lepodisiran, developed by Eli Lilly, has shown a significant reduction in lipoprotein(a) [Lp(a)] levels—by an impressive…
Read More »